Download PDF

Published: 11 July 2016

Authors:

Review of the third New Zealand Lung Day, a multidisciplinary expert forum held on 18 March 2016. 

This review features summaries of presentations that covered a wide range of topics including under-treatment in COPD, circulating plasma DNA and T790M mutations in NSCLC, and the role of the gut and lung microbiome in lung diseases.

The meeting featured local and international speakers and was attended by respiratory physicians, oncologists, pathologists, and nurse specialists, in addition to respiratory researchers, trial co-ordinators and study nurses.

  • Smokefree 2025
  • The NZ B-blocker study
  • Palliative care in COPD
  • COPD: can we add under-treated to under-diagnosed? 
  • Air Supply data sub-analysis
  • Circulating plasma DNA
  • The EGFR Mutation Testing Study
  • T790M mutation in NSCLC resistance
  • Bronchoscopic lung volume reduction in COPD
  • The role of the lung microbiome in lung diseases
  • The role of the gut microbiome in lung diseases